Proteomics and rare diseases скачать в хорошем качестве

Proteomics and rare diseases

Dr. Matthew Brown, Chief Scientific Officer at Genomics England, shares results from a pilot project with Illumina Protein Prep, screening ~1500 participants with rare diseases to demonstrate the power of NGS-based proteomics for biomarker discovery.  Subscribe to the Illumina video channel http://www.youtube.com/subscription_c... A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. To learn more about Illumina Protein Prep, visit www.illumina.com/proteinprep For research use only. Not for diagnostic purposes. View customer spotlight videos    • Illumina Customer Testimonials   View Illumina webinars    • Webinars   View Illumina support videos    • Illumina Support   LinkedIn:   / illumina   X: https://x.com/illumina Instagram:   / illuminainc   Facebook:   / illuminainc   TikTok:   / illuminainc   #illumina #multiomics #proteomics #somamer #raredisease